The Progress of Pancreatectomy for Pancreatic Cancer Treatment

Dear Colleagues,

Pancreatic cancer represents one of the most challenging areas in gastrointestinal oncology. Surgery plays a key role in pancreatic cancer therapy because surgical resection is a precondition for curative treatment. Major advances have been achieved in pancreatic surgery, with a significant improvement of perioperative outcome parameters due to centralisation in specialised centres. Recurrence-free survival and overall survival have been found to increase following multimodal therapy, with surgery being of decisive influence. However, research defining the role of surgery in multimodal treatment regimens, with special attention paid to resectability and extended resections, as well as the potential significance of minimally invasive resection—whether laparoscopic or robotic—is crucial for pancreatic cancer surgery in the future.

This Special Issue welcomes research in the topics: (a) surgery in the setting of multimodal therapy; (b) timing of surgery according to the status of resectability; (c) minimally invasive resection; (d) outcome research for resectable pancreatic cancer; (e) technique and results of extended pancreatectomy; (f) therapy of postoperative pancreatic fistulas Grad B or C; and (g) pancreatic cancer resection in portal hypertension.

Prof. Dr. Reinhold Függer
Prof. Dr. Matthias Biebl
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• pancreatic ductal adenocarcinoma (PDAC)
• pancreatectomy timing in multimodal regimen
• minimally invasive pancreatectomy for PDAC
• pancreatectomy and resectability
• extended pancreatectomy
• vascular resection and reconstruction
• outcome research—pancreatectomy for cancer in unselected patient cohorts
• interaction of postoperative complications and preoperative or adjuvant therapy
• postoperative pancreatic fistula

Title: Pancreatectomy requiring Celiac Axis Resection and Reconstruction for Locally Advanced Pancreatic cancer
Authors: Satoshi Mizutani; Nobuhiko Taniai; Takahiro Haruna; Hiroyasu Furuki; Hideyuki Takata; Junji Ueda; Masato Yoshioka; Takayuki Aimoto; Yoshiharu Nakamura*; Hiroshi Yoshida**
Affiliation: Digestive Surgery, Nippon Medical School Musashikosugi Hospital. *Department of Surgery, Nippon Medical School Chiba Hokuso Hospital **Department of Surgery, Nippon Medical School 1-383 Kosugimachi, Nakahara, Kawasaki, Kanagawa. Japan. 211-8533